Staying Aware

• This RSS feed URL is deprecated
  Source: Scleroderma AwarePublished on 2018-04-06
• Immunotherapy for type 1 diabetes: what’s in the pipeline? – The Pharmaceutical Journal
  Source: Scleroderma AwarePublished on 2018-04-05
• FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial … – PR Newswire (press release)
  Source: Scleroderma AwarePublished on 2018-03-19